针对肠道改善CDKL5缺陷障碍 (CDD) 中的控制:单臂,开放标签临床试验的研究协议
Francesca Triva1, Elisa Borghi1, Matteo Domenico Marsiglia1
1Department of Health Sciences, University of Milan, Milan, Italy.
Frontiers in neurology
|November 13, 2025
概括
这项研究调查了针对肠-大脑轴的研究,以治疗循环素依赖的类似5酶缺乏障碍 (CDD). 用特定营养素和甲酸盐补充可能会减少发作,并改善CDD患者的肠道微生物群.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 循环素依赖性酶类5缺乏障碍 (CDD) 是一种严重的神经发育状况,具有婴儿发作的,目前没有治疗方法.
- 在CDD中对标准抗药物具有耐药性,对发育产生负面影响.
- 患有CDD的患者表现出胃肠道问题和肠道微生物群的改变,这表明肠-大脑轴作为治疗点.
研究的目的:
- 在CDD患者中评估两步肠道微生物群-大脑轴干预.
- 评估α-乳蛋白,FOS,胰岛素和酸盐补充剂对神经和胃肠道症状的疗效.
- 探索这种干预对肠道微生物群组成和多样性的影响.
主要方法:
- 一项为期24周的研究涉及两个补充阶段:12周的ALAC/FOS/胰岛素,接下来是12周的ALAC/FOS/胰岛素加酸盐 (NaB).
- 监测临床参数,包括发作频率,睡眠和胃肠道不适.
- 分析便样本以鉴定肠道微生物组的变化.
主要成果:
- 这项研究旨在确定补充剂的策略是否可以改善CDD的神经特征.
- 研究干预对肠道微生物群组成的影响是主要目标.
- 评估这种方法在缓解和相关并发症方面的潜力.
结论:
- 准肠-大脑轴为CDD提供了一个新的治疗策略.
- 这种干预可能为治疗和改善CDD患者的生活质量提供了一条新的途径.
- 需要进一步的研究来证实这种方法的有效性和长期益处.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
616
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
616
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K


